aquanaz

Generic: dextromethorphan hydrobromide, guaifenesin and phenylephrine hydrochloride

Labeler: capital pharmaceutical, llc
NDC Directory HUMAN OTC DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name aquanaz
Generic Name dextromethorphan hydrobromide, guaifenesin and phenylephrine hydrochloride
Labeler capital pharmaceutical, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

dextromethorphan hydrobromide 15 mg/1, guaifenesin 400 mg/1, phenylephrine hydrochloride 10 mg/1

Manufacturer
Capital Pharmaceutical, LLC

Identifiers & Regulatory

Product NDC 29978-587
Product ID 29978-587_4485648d-222a-31b7-e063-6394a90a84e8
Product Type HUMAN OTC DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2015-03-10

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 29978587
Hyphenated Format 29978-587

Supplemental Identifiers

RxCUI
1552200
UPC
0729978587015
UNII
9D2RTI9KYH 495W7451VQ 04JA59TNSJ
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aquanaz (source: ndc)
Generic Name dextromethorphan hydrobromide, guaifenesin and phenylephrine hydrochloride (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 15 mg/1
  • 400 mg/1
  • 10 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (29978-587-01)
source: ndc

Packages (1)

29978-587-01 100 TABLET in 1 BOTTLE (29978-587-01)

Ingredients (3)

dextromethorphan hydrobromide (15 mg/1) guaifenesin (400 mg/1) phenylephrine hydrochloride (10 mg/1)

Linked Drug Pages (1)

Aquanaz ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4485648d-222a-31b7-e063-6394a90a84e8", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0729978587015"], "unii": ["9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1552200"], "spl_set_id": ["5e9e4dfd-4def-4756-9bba-d25068640101"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Capital Pharmaceutical, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (29978-587-01)", "package_ndc": "29978-587-01", "marketing_start_date": "20150310"}], "brand_name": "Aquanaz", "product_id": "29978-587_4485648d-222a-31b7-e063-6394a90a84e8", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "29978-587", "generic_name": "Dextromethorphan Hydrobromide, Guaifenesin and Phenylephrine Hydrochloride", "labeler_name": "Capital Pharmaceutical, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aquanaz", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "15 mg/1"}, {"name": "GUAIFENESIN", "strength": "400 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/1"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20150310", "listing_expiration_date": "20261231"}